Controlled attenuation parameter-insulin resistance (CIR) score to predict non-alcoholic steatohepatitis.
Saved in:
| Title: | Controlled attenuation parameter-insulin resistance (CIR) score to predict non-alcoholic steatohepatitis. |
|---|---|
| Authors: | Macias J; Departamento de Medicina, Universidad de Sevilla, Sevilla, Spain. jmacias7@us.es.; Unit of Infectious Diseases and Microbiology, Hospital Universitario Virgen de Valme, Avda Bellavista Sn, 41014, Sevilla, Spain. jmacias7@us.es.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain. jmacias7@us.es.; Instituto de Biomedicina de Sevilla (IBiS), Sevilla, Spain. jmacias7@us.es., Parra-Membrives P; Unit of Hepatobiliary and Pancreatic Surgery. Service of General and Digestive Surgery, Hospital Universitario Virgen de Valme, Sevilla, Spain., Sosa-Moreno F; Unit of Pathology, Hospital Universitario Virgen de Valme, Sevilla, Spain., Rincon P; Unit of Infectious Diseases and Microbiology, Hospital Universitario Virgen de Valme, Avda Bellavista Sn, 41014, Sevilla, Spain., Martinez-Baena D; Unit of Hepatobiliary and Pancreatic Surgery. Service of General and Digestive Surgery, Hospital Universitario Virgen de Valme, Sevilla, Spain., Fernandez-Fuertes M; Unit of Infectious Diseases and Microbiology, Hospital Universitario Virgen de Valme, Avda Bellavista Sn, 41014, Sevilla, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Lorente-Herce JM; Unit of Hepatobiliary and Pancreatic Surgery. Service of General and Digestive Surgery, Hospital Universitario Virgen de Valme, Sevilla, Spain., Martinez RC; Unit of Pathology, Hospital Universitario Virgen de Valme, Sevilla, Spain., Jimenez-Riera G; Unit of Pathology, Hospital Universitario Virgen de Valme, Sevilla, Spain., Corma-Gomez A; Unit of Infectious Diseases and Microbiology, Hospital Universitario Virgen de Valme, Avda Bellavista Sn, 41014, Sevilla, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Instituto de Biomedicina de Sevilla (IBiS), Sevilla, Spain., Gonzalez-Serna A; Unit of Infectious Diseases and Microbiology, Hospital Universitario Virgen de Valme, Avda Bellavista Sn, 41014, Sevilla, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Instituto de Biomedicina de Sevilla (IBiS), Sevilla, Spain.; Departamento de Fisiología, Facultad de Farmacia, Universidad de Sevilla, Sevilla, Spain., Pineda JA; Departamento de Medicina, Universidad de Sevilla, Sevilla, Spain.; Unit of Infectious Diseases and Microbiology, Hospital Universitario Virgen de Valme, Avda Bellavista Sn, 41014, Sevilla, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Real LM; Unit of Infectious Diseases and Microbiology, Hospital Universitario Virgen de Valme, Avda Bellavista Sn, 41014, Sevilla, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Instituto de Biomedicina de Sevilla (IBiS), Sevilla, Spain.; Departamento de Especialidades Quirúrgicas, Bioquímica e Inmunología, Universidad de Málaga, Málaga, Spain. |
| Source: | Scientific reports [Sci Rep] 2022 Dec 19; Vol. 12 (1), pp. 21897. Date of Electronic Publication: 2022 Dec 19. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2045-2322 |
|---|---|
| DOI: | 10.1038/s41598-022-25931-7 |
